ResearcherKawasaki Medical SchoolNo recent work listed

Futoshi Kuribayashi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3416-3583; OpenAlex author ID A5060154322. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 10

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migration inhibitor by an in vitro chemotaxis… Last author DOI 10.1016/j.biopha.2022.113733 ↗
Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device. Last author DOI 10.1186/s12885-017-3218-4 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

明山内 · 2 shared papers, 2017–2022 · strength 0.18
- Paper Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migra… DOI 10.1016/j.biopha.2022.113733 ↗
- Paper Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mob… DOI 10.1186/s12885-017-3218-4 ↗
Masahiro Yamamura · 2 shared papers, 2017–2022 · strength 0.18
- Paper Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migra… DOI 10.1016/j.biopha.2022.113733 ↗
- Paper Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mob… DOI 10.1186/s12885-017-3218-4 ↗
Tomio Ueno · 1 shared paper, 2022 · strength 0.11
- Paper Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migra… DOI 10.1016/j.biopha.2022.113733 ↗
Shuichiro Okamoto · 1 shared paper, 2022 · strength 0.11
- Paper Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migra… DOI 10.1016/j.biopha.2022.113733 ↗
Masakiyo Sakaguchi · 1 shared paper, 2022 · strength 0.11
- Paper Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migra… DOI 10.1016/j.biopha.2022.113733 ↗
Keisuke Hino · 1 shared paper, 2022 · strength 0.11
- Paper Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migra… DOI 10.1016/j.biopha.2022.113733 ↗
Norihiko Sugisawa · 1 shared paper, 2022 · strength 0.11
- Paper Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migra… DOI 10.1016/j.biopha.2022.113733 ↗
Robert M. Hoffman · 1 shared paper, 2022 · strength 0.11
- Paper Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migra… DOI 10.1016/j.biopha.2022.113733 ↗
Yoshiyuki Yamaguchi · 1 shared paper, 2017 · strength 0.07
- Paper Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mob… DOI 10.1186/s12885-017-3218-4 ↗
Masafumi Nakamura · 1 shared paper, 2017 · strength 0.07
- Paper Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mob… DOI 10.1186/s12885-017-3218-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.